Etid klinik pou BPCO nan Miami, FL
18 etid pou BPCO ap chèche patisipan nan sit nan ak bò kote Miami (nan yon distans apeprè 30 mil). Louvri yon etid pou wè ki moun ki ka patisipe ak kijan pou kontakte ekip etid la.
Tèks ofisyèl etid la (Anglè)
Ap chèche patisipan pou yon etid? Mete l anwo paj sa a — $99 pou 30 jou →
To Evaluate the Effect of EXPD-101/FXS7553 Compared With Placebo in Patients With COPD Over 52 Weeks of Treatment
Ap rekriteFaz 2
- Suncoast Research Group, LLC Miami - Little Havana dba Flourish Research, Miami
A Study to Investigate the Efficacy and Safety of GSK5784283 (Felcorekibart) Compared With Placebo in Participants With Moderate to Very Severe COPD (PERSIST COPD-2)
Ap rekriteFaz 3
- GSK Investigational Site, Miami
A Study of Brenipatide (LY3537031) in Adult Participants With Moderate-to-Severe Chronic Obstructive Pulmonary Disease (COPD)
Ap rekriteFaz 2
- Millennium Medical Research - Miami, Miami
A Study to Investigate Airway Inflammation With Dupilumab Subcutaneously in Participants Aged ≥40 to ≤85 Years With Chronic Obstructive Pulmonary Disease.
Ap rekriteFaz 4
- University of Miami Dermatology Clinical Trials Unit- Site Number : 8400015, Miami
- Finlay Medical Research- Site Number : 8400010, Miami
Efficacy, Safety, and Tolerability Study of Lunsekimig Compared With Placebo in Adult Participants With Inadequately Controlled Chronic Obstructive Pulmonary Disease (COPD) Characterized by an Eosinophilic Phenotype
Ap rekriteFaz 3
- University of Miami Dermatology Clinical Trials Unit- Site Number : 8400078, Miami
- MCR Research- Site Number : 8400004, Miami
- Nuren Medical & Research Center- Site Number : 8400030, Miami
- ak 1 plis
Efficacy, Safety, and Tolerability Study of Lunsekimig Compared With Placebo in Adult Participants With Inadequately Controlled Chronic Obstructive Pulmonary Disease (COPD), Characterized by an Eosinophilic Phenotype
Ap rekriteFaz 3
- DL Research Solutions- Site Number : 8400140, Miami
- Phoenix Medical Research - Miami - 24th Street- Site Number : 8400027, Miami
- Professional Research Center- Site Number : 8400046, Miami
- ak 2 plis
A Study to Investigate the Effect of AZD6793 in Participants With Moderate to Very Severe Chronic Obstructive Pulmonary Disease
Ap rekriteFaz 2
- Research Site, Miami
- Research Site, Miami
- Research Site, Miami
- ak 2 plis
A Study to Investigate the Efficacy and Safety of Tezepelumab in Adult Participants With Moderate to Very Severe COPD (D5241C00006)
Ap rekriteFaz 3
- Research Site, Miami
- Research Site, Miami
- Research Site, Miami
A Study to Investigate the Efficacy and Safety of Tezepelumab in Adult Participants With Moderate to Very Severe COPD (D5241C00007)
Ap rekriteFaz 3
- Research Site, Miami
A Study to Learn About the Study Medicine Called PF-07275315 in People With Moderate to Severe Chronic Obstructive Pulmonary Disease
Ap rekriteFaz 2/3
- Reed Medical Research, Miami
Rademikibart IV for Acute Asthma and COPD Exacerbation
Ap rekriteFaz 2
- Columbus Clinical Services, LLC, Miami
- Pharmax Research of South Florida, Inc., Miami
A Study Evaluating the Efficacy of Budesonide, Glycopyrronium and Formoterol Fumarate Metered Dosed Inhaler on Cardiopulmonary Outcomes in Chronic Obstructive Pulmonary Disease
Ap rekriteFaz 3
- Research Site, Miami
- Research Site, Miami
A Non-inferiority Pharmacokinetic and Safety/Tolerability Study of Two Different Doses of Weekly SC Alpha1-PI 15% Compared With Corresponding Standard IV Alpha1-PI in Participants With Alpha1-Antitrypsin Deficiency (AATD)
Ap rekriteFaz 3
- GC2501 Study Site 105, Miami
eValuating the Efficacy and Safety of InitiatinG depemokImab earLy therApy iN Chronic Obstructive Pulmonary Disorder (COPD) With Type 2 Inflammation
Ap rekriteFaz 3
- GSK Investigational Site, Miami
- GSK Investigational Site, Miami
- GSK Investigational Site, Miami
Physiologic Effects of Nasal High Flow on Exercise Tolerance in COPD
Ap rekrite
- University of Miami, Miami
Depemokimab as an Extended treatmeNt Duration Biologic in Adults With Chronic Obstructive Pulmonary Disease (COPD) and Type 2 Inflammation (ENDURA-2)
Ap rekriteFaz 3
- GSK Investigational Site, Miami
- GSK Investigational Site, Miami
- GSK Investigational Site, Miami
- ak 4 plis
Depemokimab as an Extended treatmeNt Duration Biologic in Adults With Chronic Obstructive Pulmonary Disease (COPD) and Type 2 Inflammation (ENDURA -1)
Ap rekriteFaz 3
- GSK Investigational Site, Miami
myAirvo 3 (High Flow Nasal Therapy; HFNT) for COPD Patients in the Home
Ap rekrite
- Reliable Research, Inc., Miami
- NewGen Health Group, Miami
Etid BPCO nan lòt vil
- Philadelphia, PA22 etid
- Birmingham, AL17 etid
- Boston, MA17 etid
- Houston, TX15 etid
- Orlando, FL15 etid
- Chicago, IL14 etid
- Baltimore, MD13 etid
- Dallas, TX12 etid
- Pittsburgh, PA12 etid
- New York City, NY11 etid
- Winston-Salem, NC9 etid
- Charlotte, NC9 etid
Lòt etid nan Miami
- Kansè nan tete42 etid
- Kansè (tout kalite)36 etid
- Kansè Poumon ki pa ti selil31 etid
- Obèsite27 etid
- Kansè pwostat27 etid
- Leksemi mieloïd egi24 etid
- Sipwa23 etid
- Kansè ovè23 etid
- Kansè Metastatik23 etid
- Kolit Ulseratif22 etid
- Myelom Miltip21 etid
- Kansè poumon20 etid
Sous ClinicalTrials.gov, done yo ranmase Oct 1, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.